Forrester Research continues to run a uniquely conservative balance sheet. Check out the technical analysis of FORR stock and ...

Albemarle's Q1'25 results show resilience despite low lithium prices. Discover why the stock offers prime valuation with ...

Company had a strong start to 2025, emerging as an R&D-focused organization Exclusive license agreement with Novo Nordisk for LX9851 executed; IND-enabling studies on track for completion in 2025 Phas ...